Abstract

Capital Structure, Liquidity and Investment Growth of Listed Conglomerate Firms in Nigeria: Moderating Effect of Firm Size

Full Text
Published version (Free)

Talk to us

Join us for a 30 min session where you can share your feedback and ask us any queries you have

Schedule a call

Similar Papers

Paper Title
Journal
Date
Author
Capital Structure and Investment Growth Opportunity of Listed Pharmaceutical Firms in Nigeria
Shehu Usman Hassan ... Joseph Aitimon
Asian Business Research | VOL. 2
Shehu Usman Hassan, et. al.Shehu Usman Hassan ... Joseph Aitimon
14 Mar 2017
An Assessment of the Organizational Size Influence on Debt to Equity Ratio among Insurance Firms in Nigeria Stock Market
Kevin Okoh Ugwu ... Chris Chukwuemeka Mbah
International Journal of Academic Research in Economics and Management Sciences | VOL. 7
Kevin Okoh Ugwu, et. al.Kevin Okoh Ugwu ... Chris Chukwuemeka Mbah
29 Jun 2018
Firm Size and Revenue Reserve of Agricultural Firms in Nigeria
Judethadeus Chukwuebuka Oshim ... Ifeyinwa Elizabeth Nnajieze
European Journal of Accounting, Auditing and Finance Research | VOL. 11
Judethadeus Chukwuebuka Oshim, et. al.Judethadeus Chukwuebuka Oshim ... Ifeyinwa Elizabeth Nnajieze
15 Aug 2023
Capital Structure, Corporate Governance and Cost Efficiency in Selected Listed Financial Firms in Nigeria
John T Ayoola ... Ayokunle O Odusina
Economy, Business and Development: An International Journal | VOL. 4
John T Ayoola, et. al.John T Ayoola ... Ayokunle O Odusina
31 May 2023
View more papers

More From: Zenodo (CERN European Organization for Nuclear Research)

Paper Title
Journal
Date
Author
Differences in the genomic diversity, structure and inbreeding patterns in wild and managed populations of Agave potatorum used in the production of Tobalá mezcal in Southern México.
Zenodo (CERN European Organization for Nuclear Research) | VOL. -
10 Jul 2024
Data for peer review
...
Zenodo (CERN European Organization for Nuclear Research) | VOL. -
, et. al. ...
30 Jun 2024
Therapy-induced APOBEC3A drives evolution of resistance to targeted therapies in non-small cell lung cancer
...
Zenodo (CERN European Organization for Nuclear Research) | VOL. -
, et. al. ...
17 May 2024
How long should my personal statement be dermatology residency?
Zenodo (CERN European Organization for Nuclear Research) | VOL. -
10 May 2024
View more papers